Amid Debt Crisis, Life Science Firms Still See Vibrant European Market | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Despite forecasts that the European economic crisis would result in sharp slashes in life science research funding, many companies operating in the space say they are seeing no proof of such reductions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.